Literature DB >> 2651040

Postinfluenza toxic shock syndrome.

G C Prechter1, A K Gerhard.   

Abstract

Postinfluenza toxic shock syndrome is a recently described entity that results from a respiratory tract infection with toxin-producing Staphylococcus aureus following an episode of influenza or influenzalike illness. This report describes a 19-year-old man who developed an influenza B respiratory infection complicated by staphylococcal pneumonia and toxic shock syndrome. The patient improved rapidly with specific antibiotic therapy, emphasizing the importance of considering this otherwise highly lethal syndrome in any individual who becomes critically ill after an initial influenzalike illness.

Entities:  

Mesh:

Year:  1989        PMID: 2651040     DOI: 10.1378/chest.95.5.1153

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  4 in total

1.  Coinfection with Staphylococcus aureus increases risk of severe coagulopathy in critically ill children with influenza A (H1N1) virus infection.

Authors:  Trung Nguyen; Ursula G Kyle; Nancy Jaimon; M Hossein Tcharmtchi; Jorge A Coss-Bu; Fong Lam; Jun Teruya; Laura Loftis
Journal:  Crit Care Med       Date:  2012-12       Impact factor: 7.598

2.  Fatal Fulminant Pneumonia Caused by Methicillin-Sensitive Staphylococcus aureus Negative for Major High-Virulence Factors Following Influenza B Virus Infection.

Authors:  Katsunori Masaki; Makoto Ishii; Masaki Anraku; Ho Namkoong; Ryo Miyakawa; Takeshi Nakajima; Koichi Fukunaga; Katsuhiko Naoki; Sadatomo Tasaka; Kenzo Soejima; Koichi Sayama; Kayoko Sugita; Satoshi Iwata; Longzhu Cui; Hideaki Hanaki; Naoki Hasegawa; Tomoko Betsuyaku
Journal:  Am J Case Rep       Date:  2015-07-14

3.  Unusual staphylococcal toxic shock syndrome presenting as a scarlet-like fever.

Authors:  D O Andrey; T Ferry; N Siegenthaler; C Fletcher; A Calmy; G Lina; S Emonet
Journal:  New Microbes New Infect       Date:  2015-08-18

Review 4.  Complications of viral influenza.

Authors:  Michael B Rothberg; Sarah D Haessler; Richard B Brown
Journal:  Am J Med       Date:  2008-04       Impact factor: 4.965

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.